Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology (Internal Medicine) Physician in Chicago, IL
NPI: 1093774465Primary Practice Location
RUSH UNIVERSITY MEDICAL CENTER
1620 W Harrison St, Chicago, IL
Primary Employer
Rush University Internists
rush.edu
HQ Phone
Get M.D. Parameswaren's Phone Numberphone_androidMobile
Get M.D. Parameswaren's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
IL State Medical License
1994 - 2026
MI State Medical License
1992 - 1993
National Board of Physicians and Surgeons
Hematology
National Board of Physicians and Surgeons
Internal Medicine
Rush University Medical Center
Residency • Internal Medicine
1993 - 1994
Fellowship • Hematology and Medical Oncology
1994 - 1996
Residency • Internal Medicine
Until 1979
University of Kerala Medical College
Medical School
Until 1977
University of London
Clinical Pathology • Clinical Pathology
Until 1989
Henry Ford Health/Henry Ford Hospital
Residency • Internal Medicine
1976 - 1979
Internship • Internal Medicine
1992 - 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 428 | 552 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 176 | 176 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 151 | 185 |
| 4 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 65 | 79 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 63 | 206 |
All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies.
Authors: Brian Kim, Reem Karmali, Parameswaran Hari, Andrew Dalovisio
Journal: Blood Rev
Publication Date: 2014-09-28
Authors: Stephanie Gregory
Journal: Microsc Res Tech
Biologic characteristics of patients with hypocellular myelodysplastic syndromes
Authors: Sefer Gezer, Azra Raza
Journal: Leuk Res
Lead Sponsor: Cyclacel Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Decitabine, DRUG: Sapacitabine
Lead Sponsor: Cyclacel Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Sapacitabine, Arm I, DRUG: Sapacitabine, Arm A, DRUG: Sapacitabine, Arm B, DRUG: Sapacitabine, Arm C, DRUG: Sapacitabine, Arm D, DRUG: sapacitabine, Arm E, DRUG: sapacitabine, Arm F, DRUG: Sapacitabine, Arm G, DRUG: Sapacitabine, Arm H
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Venetoclax
